1. Cabral AR, Santiago F, Reis JP. Coexistence of reticulate acropigmentation of Kitamura and Dowling-
Degos disease. Dermatol Reports 2011; 3(2):e33. doi: 10.4081/dr.2011.e33.
2. Kim YC, Davis MD, Schanbacher CF, Su WP. Dowling- Degos disease (reticulate pigmented anomaly of
the flexures): a clinical and histopathologic study of 6 cases. J Am AcadDermatol1999;40:462-467.
3. Tang JC, Escandon J, Shiman M, Berman B. Presentation of Reticulate Acropigmentation of Kitamura and
Dowling- Degos Disease Overlap. J ClinAesthetDermatol 2012;5(5):41-43.
4. Vasudevan B, Verma R, Badwal S, Pragasam V, Moorchung N, Badad A. A case of reticulate
acropigmentation of Kitamura: Dowling Degos disease overlap with unusual clinical manifestations. Indian
J Dermatol 2014;59:290-292.
5. Betz RC, Planko L, Eigelshoven S, Hanneken S, Pasternack SM, Bussow H, et al. Loss-of-function
mutations in the keratin 5 gene lead to Dowling- Degos disease. Am J Hum Genet 2006;78:510-519.
6. Li CR, Xing QH, Li M, Qin W, Yue XZ, Zhang XJ, et al. A gene locus responsible for reticulate pigmented
anomaly of flexures maps to chromosome 17p13.3. J Invest Dermatol 2006;126:1297-1301.
7. Schmeider A, Pasternack SM, Krahl D, Betz RC, Leverkus M. Galli- Galli disease is an acantholytic
variant of Dowling- Degos disease: Additional genetic evidence in a German family. J Am AcadDermatol
2012;66:250-1.
8. Sharma R, Sharma SC, Radotra BD, Kaur S. Reticulate acropigmentation of Kitamura. ClinExpDermatol
1989;14(4):302-3.
9. Kovarik CL, Spielvogel RL, Kantor GR. Pigmentary Disorders of the Skin. In: Elder DE, Elenitsas R,
Johnson BL, Murphy GF, Xu X, editors. Lever’s histopathology of the skin. 10th ed.
Philadelphia:Lippincott Williams and Wilkins; 2009. p.689-697.
10. Wenzel J, Tappe K, Gerdsen R, Uerlich M, Phillip-Dormstonw, Bieber T, et al. Successful treatment of
Dowling- Degos disease with Er:YAG laser. DermatolSurg2002;28:748-758.
Thank you for copying data from http://www.arastirmax.com